These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1362822)

  • 1. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
    Rosenfeld CS; Nemunaitis J
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor: present use and future directions.
    Shadduck RK
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):38-42. PubMed ID: 1492233
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor: present status.
    Shadduck RK
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):1-3. PubMed ID: 1362820
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
    Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collection and use of circulating hematopoietic progenitor cells.
    Lee JH; Klein HG
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):1-22. PubMed ID: 7737936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine enhancement of peripheral blood stem cells.
    Hénon PR; Becker M
    Stem Cells; 1993 Jul; 11 Suppl 2():65-71. PubMed ID: 7691330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 11. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
    Akabutu JJ; Chan JR
    Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
    Corringham RE; Ho AD
    Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.
    Triozzi PL; Tucker F; Benzies T; Balcerzak SP
    Bone Marrow Transplant; 1996 Jul; 18(1):47-52. PubMed ID: 8831995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic colony-stimulating factors.
    Andreeff M; Welte K
    Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematopoietic growth factors.
    Tabbara IA; Robinson BE
    Anticancer Res; 1991; 11(1):81-90. PubMed ID: 1708221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
    Haas R; Ho AD; Bredthauer U; Cayeux S; Egerer G; Knauf W; Hunstein W
    Exp Hematol; 1990 Feb; 18(2):94-8. PubMed ID: 1968009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.